These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 36978120)

  • 21. Interleukin-36β exacerbates DSS-induce acute colitis via inhibiting Foxp3
    Zhu J; Xu Y; Li Z; Liu S; Fu W; Wei Y
    Int Immunopharmacol; 2022 Jul; 108():108762. PubMed ID: 35436743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GNAI1 and GNAI3 Reduce Colitis-Associated Tumorigenesis in Mice by Blocking IL6 Signaling and Down-regulating Expression of GNAI2.
    Li ZW; Sun B; Gong T; Guo S; Zhang J; Wang J; Sugawara A; Jiang M; Yan J; Gurary A; Zheng X; Gao B; Xiao SY; Chen W; Ma C; Farrar C; Zhu C; Chan OTM; Xin C; Winnicki A; Winnicki J; Tang M; Park R; Winnicki M; Diener K; Wang Z; Liu Q; Chu CH; Arter ZL; Yue P; Alpert L; Hui GS; Fei P; Turkson J; Yang W; Wu G; Tao A; Ramos JW; Moisyadi S; Holcombe RF; Jia W; Birnbaumer L; Zhou X; Chu WM
    Gastroenterology; 2019 Jun; 156(8):2297-2312. PubMed ID: 30836096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats.
    Tanaka F; Tominaga K; Ochi M; Tanigawa T; Watanabe T; Fujiwara Y; Ohta K; Oshitani N; Higuchi K; Arakawa T
    Life Sci; 2008 Dec; 83(23-24):771-9. PubMed ID: 18950645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
    Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
    Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic infusion of bone marrow-derived mesenchymal stem cells for treatment of experimental colitis in mice.
    He XW; He XS; Lian L; Wu XJ; Lan P
    Dig Dis Sci; 2012 Dec; 57(12):3136-44. PubMed ID: 22752635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human umbilical cord-derived mesenchymal stem cells downregulate inflammatory responses by shifting the Treg/Th17 profile in experimental colitis.
    Li L; Liu S; Xu Y; Zhang A; Jiang J; Tan W; Xing J; Feng G; Liu H; Huo F; Tang Q; Gu Z
    Pharmacology; 2013; 92(5-6):257-64. PubMed ID: 24280970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
    Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
    J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amelioration of DSS-induced colitis in mice by TNF-α-stimulated mesenchymal stem cells derived from feline adipose tissue via COX-2/PGE
    Kim K; An JH; Park SM; Lim G; Seo KW; Youn HY
    J Vet Sci; 2023 Jul; 24(4):e52. PubMed ID: 37532297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoscopic Administration of Mesenchymal Stromal Cells Reduces Inflammation in Experimental Colitis.
    Barnhoorn M; de Jonge-Muller E; Molendijk I; van Gulijk M; Lebbink O; Janson S; Schoonderwoerd M; van der Helm D; van der Meulen-de Jong A; Hawinkels L; Verspaget H
    Inflamm Bowel Dis; 2018 Jul; 24(8):1755-1767. PubMed ID: 29796655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human iPSC-MSC-Derived Xenografts Modulate Immune Responses by Inhibiting the Cleavage of Caspases.
    Li CL; Leng Y; Zhao B; Gao C; Du FF; Jin N; Lian QZ; Xu SY; Yan GL; Xia JJ; Zhuang GH; Fu QL; Qi ZQ
    Stem Cells; 2017 Jul; 35(7):1719-1732. PubMed ID: 28520232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6.
    Yang S; Liang X; Song J; Li C; Liu A; Luo Y; Ma H; Tan Y; Zhang X
    Stem Cell Res Ther; 2021 May; 12(1):315. PubMed ID: 34051868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesenteric lymph nodes: a critical site for the up-regulatory effect of hUC-MSCs on Treg cells by producing TGF-β1 in colitis treatment.
    Zhang Q; Zeng Z; Wei N; Su Y; Wang J; Ni Q; Wang Y; Yang J; Liu X; Xu H; Wang G; Shan Y; Zhou F
    Stem Cell Res Ther; 2024 Jul; 15(1):190. PubMed ID: 38956621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
    Luz-Crawford P; Kurte M; Bravo-Alegría J; Contreras R; Nova-Lamperti E; Tejedor G; Noël D; Jorgensen C; Figueroa F; Djouad F; Carrión F
    Stem Cell Res Ther; 2013 Jun; 4(3):65. PubMed ID: 23734780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandin E
    An JH; Song WJ; Li Q; Kim SM; Yang JI; Ryu MO; Nam AR; Bhang DH; Jung YC; Youn HY
    BMC Vet Res; 2018 Nov; 14(1):354. PubMed ID: 30453939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study the effects of mesenchymal stem cell conditioned medium injection in mouse model of acute colitis.
    Pouya S; Heidari M; Baghaei K; Asadzadeh Aghdaei H; Moradi A; Namaki S; Zali MR; Hashemi SM
    Int Immunopharmacol; 2018 Jan; 54():86-94. PubMed ID: 29112894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenchymal stem cell expression of interleukin-35 protects against ulcerative colitis by suppressing mucosal immune responses.
    Yan Y; Zhao N; He X; Guo H; Zhang Z; Liu T
    Cytotherapy; 2018 Jul; 20(7):911-918. PubMed ID: 29907361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraperitoneally Delivered Mesenchymal Stem Cells Alleviate Experimental Colitis Through THBS1-Mediated Induction of IL-10-Competent Regulatory B Cells.
    Liu J; Lai X; Bao Y; Xie W; Li Z; Chen J; Li G; Wang T; Huang W; Ma Y; Shi J; Zhao E; Xiang AP; Liu Q; Chen X
    Front Immunol; 2022; 13():853894. PubMed ID: 35371051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lupus mice derived mesenchymal stromal cells: Beneficial or detrimental on SLE disease outcome.
    Hosseini S; Mahmoudi M; Rezaieyazdi Z; Shapouri-Moghaddam A; Hosseinzadeh A; Arab FL; Tabasi NS; Esmaeili SA
    Int Immunopharmacol; 2024 Jan; 126():111306. PubMed ID: 38039717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of unlicensed bone marrow-derived platelet lysate-expanded mesenchymal stromal cells in colitis: a pre-clinical study.
    Salmenkari H; Laitinen A; Forsgård RA; Holappa M; Lindén J; Pasanen L; Korhonen M; Korpela R; Nystedt J
    Cytotherapy; 2019 Feb; 21(2):175-188. PubMed ID: 30611671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene delivery with IFN-γ-expression plasmids enhances the therapeutic effects of MSCs on DSS-induced mouse colitis.
    Chen Y; Song Y; Miao H; Xu Y; Lv M; Wang T; Hou Y
    Inflamm Res; 2015 Sep; 64(9):671-81. PubMed ID: 26153869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.